Drug Delivery Business

Tandem Diabetes Care acquires Sugarmate mobile app

By

Tandem Diabetes Care Sugarmate
Nearly 30,000 diabetes who rely on insulin use the Sugarmate app. [Image courtesy of Sugarmate]
Tandem Diabetes Care (NSDQ:TNDM) said today that it has purchased Sugarmate — as mobile app that helps people better manage their diabetes.

Financial terms of the deal were not disclosed. Nearly 30,000 people relying on insulin pumps or multiple daily injections presently use the Sugarmate app.

Sugarmate cofounder Josh Juster will join Tandem as a VP and will continue to lead Sugarmate as a wholly-owned subsidiary of the insulin pump maker.

Sugarmate’s creators designed it to help people visualize their diabetes therapy data in an innovative way. They can log glucose data and health and nutrition information and receive notifications and alerts that can also go to designated family and caregivers.

“Our acquisition of Sugarmate represents an exciting addition to our digital offerings, and supports Tandem’s strategic vision to expand our ecosystem of diabetes-related products and services,” Tandem Diabetes Care CEO John Sheridan said in a news release.

Tandem Diabetes Care officials do not intend for Sugarmate to replace their  t:connect mobile app, which is expected to launch for t:slim X2 pump users this summer.

IN CASE YOU MISSED IT

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].